Results 61 to 70 of about 920 (71)

Cockayne syndrome mice reflect human kidney disease and are defective in de novo NAD biosynthesis. [PDF]

Cell Death Differ
Pekhale K, Tiwari V, Hussain M, Bridges CC, Croteau DL, Levi M, Rosenberg AZ, Santo B, Yang X, Kulikowicz T, Wang XX, Lee JH, Bohr VA.   +12 more
europepmc   +1 more source

Break Down of the Complexity and Inconsistency Between Levels of Matriglycan and Disease Phenotype in FKRP-Related Dystroglycanopathies: A Review and Model of Interpretation. [PDF]

J Neuromuscul Dis
Lu QL, Holbrook MC, Cataldi MP, Blaeser A.   +3 more
europepmc   +1 more source

CAZac: an activity descriptor for carbohydrate-active enzymes. [PDF]

Nucleic Acids Res
Lombard V, Henrissat B, Garron ML.
europepmc   +1 more source

Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study. [PDF]

BMC Neurol
Doody A, Alfano L, Diaz-Manera J, Lowes L, Mozaffar T, Mathews KD, Weihl CC, Wicklund M, Hung M, Statland J, Johnson NE, GRASP-LGMD Consortium.   +11 more
europepmc   +1 more source

Recombinant protein expression in <i>Acanthamoeba castellanii</i>. [PDF]

Front Bioeng Biotechnol
Salunke P, Kondabagil K, Karpe YA.
europepmc   +1 more source

NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion. [PDF]

Mol Cancer Res
Noronha KJ, Lucas KN, Paradkar S, Edmonds J, Friedman S, Murray MA, Liu S, Sajed DP, Sachs C, Spurrier J, Raponi M, Liang J, Zeng H, Sundaram RK, Shuch B, Vasquez JC, Bindra RS.   +16 more
europepmc   +1 more source

C1'-Branched Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium Falciparum 6-Oxopurine Phosphoribosyltransferase. [PDF]

ChemMedChem
Frydrych J, Keough DT, Xia H, Slavětínská LP, Dračínský M, Česnek M, Travis J, Chavchich M, Edstein M, Hocková D, Guddat LW, Janeba Z.   +11 more
europepmc   +1 more source

Enhancing maize resistance to Fusarium verticillioides through modulation of cell wall structure and components by ZmXYXT2. [PDF]

J Adv Res
Xu Y, Fan Y, Liu L, Cao J, Zhou J, Liu E, Li R, Ma P, Yao W, Wu J, Li T, Zhang H.   +11 more
europepmc   +1 more source

Dual FKRP/FST gene therapy normalizes ambulation, increases strength, decreases pathology, and amplifies gene expression in LGMDR9 mice. [PDF]

Mol Ther
Lam P, Zygmunt DA, Ashbrook A, Bennett M, Vetter TA, Martin PT.   +5 more
europepmc   +1 more source

Health-Related Quality of Life in FKRP-Related Limb-Girdle Muscular Dystrophy R9. [PDF]

J Neuromuscul Dis
Jensen SM, Friborg O, Mellgren SI, Müller KI, Bergvik S, Arntzen KA.   +5 more
europepmc   +1 more source